Ireland· IE-PA-PA22902/001/001
Propylthiouracil 50 mg tablets
A propylthiouracil product containing propylthiouracil, registered in Ireland by Halewood Chemicals (Ireland) Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Propylthiouracil is registered in 14 of 19 countries.
Countries holding a registration under ATC H03BA02 (propylthiouracil), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Propylthiouracil · ATC H03BA02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of propylthiouracil costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.89 in Switzerland to $1.64 in France — a ×1.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Propylthiouracil · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FR France$1.64
- CH Switzerland$0.89
The record
At a glance
HPRA (Ireland)- Active substance
- Propylthiouracil
- Manufacturer
- Halewood Chemicals (Ireland) Limited
- Country
- Ireland (IE)
- ATC code
- H03BA02
- ATC class
- Propylthiouracil
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA22902/001/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
92 interactions on record for propylthiouracil.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Propylthiouracil · interactions on record
92 records
- 9 severe
- 41 moderate
- 42 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Propylthiouracil in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPropylthiouracil 50mg tabletsTeva UK Ltd
- United StatesPropylthiouracilEndo USA, Inc.
- CzechiaPROPYCILAdmeda Arzneimittel GmbH, Hamburg
- PolandPropycil 50 mgAdmeda Arzneimittel GmbH
- CanadaHALYCILHALEWOOD CHEMICALS LIMITED
- FrancePROPYLEX 50 mg, compriméASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - AP-HP
- SwitzerlandPropycil 50, TablettenCuratis AG
- NetherlandsPropylthiouracil Aurobindo 50 mg, tablettenAurobindo Pharma B.V.
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Prothiucil
- Belgium · Propylthiouracil Orifarm, Propylthiouracile Orifarm
- Bulgaria · Propycil
- Cyprus · Prothuril
- Czechia · Propycil
- Germany · Propycil, Thyreostat Ii
- Denmark · Propyltiouracil Medic
- France · Propylex
- United Kingdom (Northern Ireland) · Propylthiouracil Blue Bio Pharma (Uk) Limited, Propylthiouracil Halewood Chemicals
- Greece · Prothuril
- Croatia · Propiltiouracil Alkaloid
- Hungary · Propycil
- Luxembourg · Propylthiouracile Orifarm
- Malta · Propylthiouracil Halewood Chemicals (Ireland)
- Netherlands · Propylthiouracil Aurobindo
- Poland · Thyrosan
- Portugal · Propycil
- Slovakia · Propycil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d73c455d-af22-47ea-aedf-b31911d2c2d2 GET /v1/drugs/d73c455d-af22-47ea-aedf-b31911d2c2d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"H03BA",
"H03BA02"
],
"strength": null,
"pa_number": "PA22902/001/001",
"substances": [
"Propylthiouracil"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "10/02/2017",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about propylthiouracil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.